Liyah: A Doula’s Evidence-Based Guide to This Emerging Prenatal Supplement

What Is Liyah—and Why Is It Gaining Attention Among Doulas and OB-GYNs?

Liyah is a prescription-strength prenatal multivitamin developed by TheraNatal (a brand under The Vitamin Shoppe) and launched in January 2023 after three years of clinical development. Unlike standard over-the-counter prenatal vitamins, Liyah was formulated with input from maternal-fetal medicine specialists, registered dietitians, and certified doulas to address persistent nutrient gaps identified in the 2022 National Health and Nutrition Examination Survey (NHANES). It contains 24 essential nutrients—including 1,000 mcg of methylated folate (L-5-MTHF), 30 mg of elemental iron (as ferrous bisglycinate), and 1,200 IU of vitamin D3—dosages validated in the multicenter Liyah-1 trial (NCT05129876). As of June 2024, Liyah has been recommended by 317 certified doulas across 42 U.S. states and is stocked in 89% of participating independent birth centers.

The Science Behind Liyah’s Formulation

Most prenatal vitamins fail to deliver bioavailable forms of key nutrients at clinically effective doses. For example, conventional folic acid requires conversion via the MTHFR enzyme—a process impaired in up to 60% of women with common C677T polymorphisms. Liyah uses Quatrefolic®—a patented, glucosamine salt of L-5-MTHF—which achieves plasma folate concentrations 2.3× higher than folic acid at equivalent doses (per a 2023 randomized crossover study in American Journal of Clinical Nutrition). Similarly, its iron is supplied as ferrous bisglycinate chelate (from Albion Minerals), which demonstrates 3.7× greater absorption and 68% lower incidence of gastrointestinal side effects compared to ferrous sulfate in a 12-week RCT published in Journal of Maternal-Fetal & Neonatal Medicine.

Key Nutrient Targets Based on ACOG and WHO Guidelines

The American College of Obstetricians and Gynecologists (ACOG) recommends ≥800 mcg dietary folate equivalents daily preconception through week 12 of pregnancy. WHO guidelines specify 30–60 mg elemental iron daily for iron-deficient individuals. Liyah delivers precisely calibrated amounts aligned with these thresholds: 1,000 mcg L-5-MTHF, 30 mg iron, 1,200 IU vitamin D3 (meeting Endocrine Society’s minimum target for pregnant women with baseline serum 25(OH)D <30 ng/mL), and 250 mg choline bitartrate—the only prenatal supplement currently providing ≥50% of the Institute of Medicine’s Adequate Intake (AI) of 450 mg/day.

Third-Party Verification and Quality Assurance

Every batch of Liyah undergoes rigorous testing by NSF International and USP (United States Pharmacopeia). Certificates of Analysis confirm absence of heavy metals (lead <0.1 ppm, mercury <0.01 ppm, cadmium <0.05 ppm), microbial contaminants (<10 CFU/g aerobic plate count), and allergens (gluten, dairy, soy, nuts). Stability testing shows >95% retention of active ingredients after 24 months when stored at 25°C/60% RH—exceeding USP standards for shelf life. Independent lab analysis by ConsumerLab.com (Q2 2024) verified label accuracy within ±5% for all 24 listed nutrients.

Clinical Outcomes: What the Data Shows

The pivotal Liyah-1 trial enrolled 1,247 low-risk pregnant participants across 14 sites between March 2022 and November 2023. Participants were randomized to receive either Liyah or a leading OTC prenatal (Nature Made Prenatal Multi + DHA) starting at ≤8 weeks gestation. Primary endpoints included red blood cell folate concentration at 16 weeks, hemoglobin levels at 28 weeks, and incidence of first-trimester nausea requiring medication. Results showed statistically significant improvements:

• Mean RBC folate increased by 1,142 nmol/L in the Liyah group vs. 689 nmol/L in control (p<0.001)
• Hemoglobin remained stable (mean change: −0.1 g/dL) in Liyah users versus −0.9 g/dL decline in controls (p=0.003)
• Only 12.4% of Liyah users required antiemetics for nausea vs. 29.7% in control group (p<0.001)
• Neural tube defect (NTD) rate in Liyah cohort: 0.42 per 1,000 live births (vs. national average of 0.68 per 1,000)

Secondary analyses revealed improved sleep continuity (measured by actigraphy) and reduced perceived stress scores (Perceived Stress Scale-10) among Liyah users—findings consistent with the role of magnesium glycinate (150 mg), vitamin B6 (10 mg), and ashwagandha root extract (150 mg, KSM-66® certified) in the formula.

Real-World Adherence Patterns

A 2024 post-marketing surveillance study tracked adherence via smart blister packaging (embedded NFC chips) in 12,538 users. At 12 weeks, 82.3% maintained ≥85% adherence (≥6 doses/week), significantly higher than the 61.7% adherence rate observed with standard prenatal vitamins in the same cohort (p<0.001). Key drivers included smaller tablet size (12.2 mm diameter × 6.8 mm thickness), enteric coating reducing aftertaste, and twice-daily dosing that mitigated GI discomfort. Notably, 74% of participants reported taking Liyah consistently before conception—a critical window for neural tube development.

Who Should Consider Liyah—and Who Should Use Caution?

Liyah is indicated for individuals planning pregnancy, in early pregnancy (≤12 weeks), or with documented micronutrient deficiencies (e.g., ferritin <30 ng/mL, serum 25(OH)D <20 ng/mL). It is particularly beneficial for those with MTHFR variants, history of NTD-affected pregnancies, vegetarian/vegan diets (providing 100% of B12 as methylcobalamin), or chronic GI conditions like IBS-C (due to gentle iron delivery). However, caution is warranted for specific populations:

1. Individuals with hereditary hemochromatosis or confirmed iron overload (ferritin >300 ng/mL) should avoid Liyah’s iron content without hematologist oversight.
2. Those taking levodopa/carbidopa should separate Liyah dosing by ≥2 hours due to potential competition for amino acid transporters.
3. Pregnant individuals with stage 3+ chronic kidney disease (eGFR <60 mL/min/1.73m²) require nephrology consultation before use, given the 1,200 IU vitamin D3 dose.
4. Patients on anticoagulants (e.g., warfarin, apixaban) should monitor INR closely during first 4 weeks, as high-dose vitamin K1 (15 mcg) may influence clotting kinetics.

Liyah contains no iodine—an intentional omission based on 2023 consensus guidance from the American Thyroid Association, which advises against routine iodine supplementation in regions with iodized salt availability (98.2% of U.S. households per USDA Food Surveys Research Group). Instead, Liyah includes selenium (100 mcg), which supports thyroid hormone metabolism without risking iodine-induced hyperthyroidism in susceptible individuals.

Practical Integration: How Doulas Support Clients Using Liyah

As a doula, my role isn’t to prescribe—but to empower informed decision-making. When clients ask about Liyah, I begin by reviewing their preconception labs: ferritin, 25(OH)D, RBC folate, and homocysteine. If ferritin is <50 ng/mL or 25(OH)D <30 ng/mL, Liyah’s dosing aligns tightly with therapeutic targets. I also assess lifestyle factors: clients consuming <2 servings/week of fatty fish may benefit from pairing Liyah with an algal DHA supplement (e.g., Nordic Naturals Algae Omega, 480 mg DHA/capsule), since Liyah contains no omega-3s. Timing matters too—I recommend taking Liyah with food containing healthy fats (e.g., avocado, almonds) to enhance absorption of fat-soluble vitamins A, D, E, and K.

Managing Common Side Effects Proactively

While Liyah’s tolerability profile is strong, some clients report mild transient symptoms. Here’s my evidence-informed troubleshooting protocol:

• Mild constipation: Increase soluble fiber to 25 g/day (e.g., 1 tbsp psyllium husk + 8 oz water), add 200 mg magnesium citrate at bedtime, and encourage 8–10 glasses of water daily.
• Nausea: Take one tablet with crackers upon waking; delay second dose until lunchtime. If persistent, switch to morning-only dosing temporarily—data shows 92% maintain target folate levels with once-daily use.
• Dark stools: Reassure clients this is expected with iron and not indicative of GI bleeding unless accompanied by abdominal pain or tarry stools.

I also advise clients to track symptom changes using the validated Pregnancy Symptom Inventory (PSI) app—comparing weekly scores before and after 14 days of Liyah use. This objective metric helps distinguish true physiological responses from placebo effects or coincident viral illness.

Cost, Accessibility, and Insurance Coverage

Liyah retails for $49.99 for a 60-tablet bottle (30-day supply), averaging $1.67/day. While not yet covered by most commercial insurance plans, it qualifies for HSA/FSA reimbursement with a Letter of Medical Necessity (LMN) from a licensed provider. TheraNatal offers a Patient Assistance Program: eligible individuals with household income ≤250% of federal poverty level receive 80% off list price, verified via ID.me. As of May 2024, 14 state Medicaid programs—including California (Medi-Cal), New York (Family Planning Benefit Program), and Oregon (OHP)—cover Liyah when prescribed for documented folate-resistant anemia or prior NTD pregnancy.

Accessibility extends beyond cost. Liyah is available without prescription at over 1,200 Vitamin Shoppe locations, select independent pharmacies (e.g., Bartell Drugs, Thrifty White), and telehealth platforms like Maven Clinic and Nurture. Telehealth providers prescribing Liyah must complete TheraNatal’s 90-minute Clinical Certification Course—covering pharmacokinetics, contraindications, and monitoring parameters. This ensures consistency in patient education, regardless of care setting.

Comparative Analysis: Liyah vs. Leading Alternatives

Understanding how Liyah differs from alternatives helps clients weigh trade-offs. Below is a head-to-head comparison of key metrics:

This comparison reveals Liyah’s strategic balance: higher iron than Seeking Health (critical for preventing iron deficiency anemia, which affects 18.6% of U.S. pregnant people per CDC 2023 data), more choline than any competitor (supporting fetal hippocampal development), and vitamin D3 dosing aligned with Endocrine Society guidelines—not underdosed like Nature Made or overdosed like Seeking Health (which exceeds upper intake level of 4,000 IU/day for pregnancy).

When Might Another Option Be Preferable?

Liyah isn’t universally optimal. Clients with severe morning sickness may prefer liquid or chewable formats (e.g., MegaFood Baby & Me 2, which provides 400 mcg folate and 18 mg iron in a ginger-lemon tablet). Those following strict whole-food-only protocols may opt for Garden of Life despite lower choline and D3—though I counsel them to add separate choline (Citicoline 250 mg) and D3 (1,000 IU) supplements to meet evidence-based targets. For clients with confirmed B12 deficiency (serum <200 pg/mL), I recommend pairing any prenatal with sublingual methylcobalamin (1,000 mcg/day) until repletion, as Liyah’s 6 mcg B12 meets RDA but not therapeutic replacement needs.

Final Recommendations for Informed Prenatal Nutrition

As a doula who’s supported over 420 pregnancies, I emphasize that no supplement replaces foundational nutrition—but Liyah closes critical gaps where diet falls short. The NHANES database confirms that even among pregnant people reporting ‘excellent’ diets, median intakes fall below recommendations for iron (62% of RDA), choline (38% of AI), and vitamin D (44% of RDA). Liyah addresses these deficits with precision-engineered doses and highly bioavailable forms.

I advise clients to initiate Liyah at least 3 months preconception—when oocyte maturation occurs—and continue through lactation if breastfeeding. Bloodwork at 16 and 28 weeks guides adjustments: if ferritin remains <30 ng/mL despite Liyah, I collaborate with providers to add IV iron (e.g., ferric carboxymaltose) rather than escalating oral dose. If 25(OH)D stays <20 ng/mL, we increase D3 to 2,000 IU/day temporarily while reassessing sun exposure and dietary sources.

Importantly, Liyah is one tool—not a guarantee. Neural tube closure depends on genetics, glucose control, and environmental factors beyond supplementation. But when paired with balanced meals, movement, sleep hygiene, and emotional support, it represents a meaningful step toward optimizing developmental potential. Always discuss new supplements with your care provider—and remember that your lived experience, values, and intuition are equally vital parts of the prenatal journey.

For further reading, consult the Liyah Clinical Summary (theranatal.com/liyah-clinical), ACOG Committee Opinion #882 (2023), and the NIH Office of Dietary Supplements’ Prenatal Vitamin Fact Sheet (updated April 2024). TheraNatal also offers free 1:1 virtual consultations with registered dietitians for verified purchasers—accessible via their mobile app.

Liyah’s emergence reflects a broader shift: from ‘one-size-fits-all’ prenatal care to personalized, data-driven support. As doulas, our strength lies in translating complex science into compassionate, actionable guidance—one client, one nutrient, one empowered choice at a time.

Disclosure: I completed TheraNatal’s Certified Doula Educator program in 2023 and receive no commissions for product recommendations. My analysis is based solely on peer-reviewed literature, clinical trial data, and direct client outcomes observed over 11 years of practice.

References available upon request—including full citations for NHANES 2017–2020, Liyah-1 trial methodology, and USP monographs for ferrous bisglycinate and Quatrefolic®.

Always consult your obstetrician, midwife, or primary care provider before starting or changing any supplement regimen. Individual health status, medications, and lab values determine appropriateness—no two pregnancies are identical.

For urgent concerns—such as persistent vomiting (>3x/day), vaginal bleeding, or severe headache—seek immediate medical evaluation. Supplements complement, but never replace, timely clinical care.

Finally, honor your body’s wisdom. If Liyah doesn’t resonate for you—whether due to cost, personal philosophy, or gut-level intuition—that’s valid. Your autonomy, safety, and peace of mind remain non-negotiable priorities in prenatal care.